The FY2025 (May) proxy of Angiodynamics names 14 peer companies for pay. Among Angiodynamics and these peers, CEO pay was the lowest of 6 and total shareholder return was 5th highest of 6.
6th highest of 6in Angiodynamics and its pay peers, FY2025 (May) by CEO pay:
$5.5M$12.0M
5th highest of 6in Angiodynamics and its pay peers, FY2025 (May) by total shareholder return:
$30$192
Pay peer group, FY2025 (May) proxy
| GLAUKOS | ||
| Alphatec Holdings | ||
| AtriCure | ||
| Axogen | ||
| Staar Surgical | ||
| Accuray Incorporated | Not disclosed | Not disclosed |
| Artivian, Inc. | Not disclosed | Not disclosed |
| Atrion Corporation | Not disclosed | Not disclosed |
| Cutera, Inc. | Not disclosed | Not disclosed |
| Inari Medical, Inc. | Not disclosed | Not disclosed |
| Lemaitre Vascular | Not disclosed | Not disclosed |
| Nevro Corp. | Not disclosed | Not disclosed |
| Orthofix Medical | Not disclosed | Not disclosed |
| Surmodics, Inc. | Not disclosed | Not disclosed |
14 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.